» Articles » PMID: 1729692

Specific Inflammatory Cytokines Regulate the Expression of Human Monocyte 15-lipoxygenase

Overview
Specialty Science
Date 1992 Jan 1
PMID 1729692
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Arachidonate 15-lipoxygenase (arachidonate:oxygen 15-oxidoreductase, EC 1.13.11.33) is a lipid-peroxidating enzyme that is implicated in oxidizing low density lipoprotein to its atherogenic form. Monocyte/macrophage 15-lipoxygenase is present in human atherosclerotic lesions. To pursue a basis for induction of the enzyme, which is not present in blood monocytes, the ability of relevant cytokines to regulate its expression was investigated. Interleukin 4 (IL-4), among 16 factors tested, specifically induced 15-lipoxygenase mRNA and protein in cultured human monocytes. Interferon gamma and hydrocortisone inhibited this induction. High-performance liquid chromatography analysis of lipid extracts from IL-4-treated monocytes detected 15-lipoxygenase products esterified to the cellular membrane lipids, indicating enzymatic action on endogenous substrates. Stimulation of IL-4-treated monocytes with calcium ionophore or opsonized zymosan A enhanced the formation of 15-lipoxygenase products. These data identify IL-4 and interferon gamma as physiological regulators of lipoxygenase expression and suggest an important link between 15-lipoxygenase function and the immune/inflammatory response in atherosclerosis as well as other diseases.

Citing Articles

Genetic deletion of 12/15 lipoxygenase delays vascular remodeling and limits cardiorenal dysfunction after pressure overload.

Lee D, Kain V, Wang D, Rokosh D, Prabhu S, Halade G J Mol Cell Cardiol Plus. 2025; 5():100046.

PMID: 39802176 PMC: 11708313. DOI: 10.1016/j.jmccpl.2023.100046.


Knock-in mice expressing a humanized arachidonic acid 15-lipoxygenase (Alox15) carry a partly dysfunctional erythropoietic system.

Reisch F, Heydeck D, Schafer M, Rothe M, Yang J, Stehling S Cell Mol Biol Lett. 2023; 28(1):97.

PMID: 38030974 PMC: 10685687. DOI: 10.1186/s11658-023-00511-3.


A review on the relationship between Arachidonic acid 15-Lipoxygenase (ALOX15) and diabetes mellitus.

He K, Zhou X, Du H, Zhao J, Deng R, Wang J PeerJ. 2023; 11:e16239.

PMID: 37849828 PMC: 10578307. DOI: 10.7717/peerj.16239.


Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.

Rao Z, Brunner E, Giszas B, Iyer-Bierhoff A, Gerstmeier J, Borner F Proc Natl Acad Sci U S A. 2023; 120(35):e2302070120.

PMID: 37603745 PMC: 10469032. DOI: 10.1073/pnas.2302070120.


Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.

Rasquel-Oliveira F, da Silva M, Martelossi-Cebinelli G, Fattori V, Casagrande R, Verri Jr W Molecules. 2023; 28(13).

PMID: 37446699 PMC: 10343836. DOI: 10.3390/molecules28135032.


References
1.
Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J . Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989; 320(14):915-24. DOI: 10.1056/NEJM198904063201407. View

2.
Kuhn H, Belkner J, Wiesner R, Brash A . Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J Biol Chem. 1990; 265(30):18351-61. View

3.
Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

4.
Kikutani H, Inui S, Sato R, Barsumian E, Owaki H, Yamasaki K . Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell. 1986; 47(5):657-65. DOI: 10.1016/0092-8674(86)90508-8. View

5.
Murray J, Brash A . Rabbit reticulocyte lipoxygenase catalyzes specific 12(S) and 15(S) oxygenation of arachidonoyl-phosphatidylcholine. Arch Biochem Biophys. 1988; 265(2):514-23. DOI: 10.1016/0003-9861(88)90156-7. View